Lyfgenia gene therapies

FDA gives nod to Casgevy and Lyfgenia gene therapies for Sickle Cell Anaemia

The US Food and Drug Administration (FDA) has granted approval for two new gene therapies targeting sickle cell disease. One…

Read More »